• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自然杀伤细胞与树突状细胞:在受损伤组织中的相遇

Natural killer cells and dendritic cells: rendezvous in abused tissues.

作者信息

Moretta Alessandro

机构信息

Dipartimento di Medicina Sperimentale, Sezione di Istologia, and Centro di Eccellenza per le Ricerche Biomediche, Università degli Studi di Genova, 16132 Genova, Italy.

出版信息

Nat Rev Immunol. 2002 Dec;2(12):957-64. doi: 10.1038/nri956.

DOI:10.1038/nri956
PMID:12461568
Abstract

Natural killer (NK) cells and dendritic cells (DCs) are two types of specialized cell of the innate immune system, the reciprocal interaction of which results in a potent, activating cross-talk. For example, DCs can prime resting NK cells, which, in turn, after activation, might induce DC maturation. However, NK cells negatively regulate the function of DCs also by killing immature DCs in peripheral tissues. Moreover, a subset of NK cells, after migration to secondary lymphoid tissues, might have a role in the editing of mature DCs based on the selective killing of mature DCs that do not express optimal surface densities of MHC class I molecules. So, cognate interactions between NK cells and DCs provide a coordinated mechanism that is involved not only in the regulation of innate immunity, but also in the promotion of appropriate downstream adaptive responses for defence against pathogens.

摘要

自然杀伤(NK)细胞和树突状细胞(DC)是先天性免疫系统中的两种特殊细胞类型,它们之间的相互作用会产生强大的激活串扰。例如,DC可以激活静息的NK细胞,而激活后的NK细胞反过来可能会诱导DC成熟。然而,NK细胞也会通过杀伤外周组织中的未成熟DC来负向调节DC的功能。此外,一部分NK细胞迁移至次级淋巴组织后,可能会基于对不表达最佳表面密度MHC I类分子的成熟DC的选择性杀伤,参与成熟DC的编辑过程。因此,NK细胞与DC之间的同源相互作用提供了一种协调机制,不仅参与先天性免疫的调节,还促进针对病原体防御的适当下游适应性反应。

相似文献

1
Natural killer cells and dendritic cells: rendezvous in abused tissues.自然杀伤细胞与树突状细胞:在受损伤组织中的相遇
Nat Rev Immunol. 2002 Dec;2(12):957-64. doi: 10.1038/nri956.
2
NK-DC interaction: on the usefulness of auto-aggression.自然杀伤细胞与树突状细胞的相互作用:自身攻击的作用
Autoimmun Rev. 2005 Nov;4(8):520-5. doi: 10.1016/j.autrev.2005.04.015.
3
Pathogen-induced private conversations between natural killer and dendritic cells.病原体诱导的自然杀伤细胞与树突状细胞之间的私密对话
Trends Microbiol. 2005 Mar;13(3):128-36. doi: 10.1016/j.tim.2005.01.006.
4
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.自然杀伤细胞介导的对自体树突状细胞的杀伤作用局限于表达CD94/NKG2A但缺乏抑制性杀伤细胞免疫球蛋白样受体的细胞亚群。
Eur J Immunol. 2003 Jun;33(6):1657-66. doi: 10.1002/eji.200323986.
5
The dialogue between human natural killer cells and dendritic cells.人类自然杀伤细胞与树突状细胞之间的对话。
Curr Opin Immunol. 2005 Jun;17(3):306-11. doi: 10.1016/j.coi.2005.03.004.
6
Effector and regulatory events during natural killer-dendritic cell interactions.自然杀伤细胞与树突状细胞相互作用过程中的效应和调节事件。
Immunol Rev. 2006 Dec;214:219-28. doi: 10.1111/j.1600-065X.2006.00450.x.
7
Role of natural killer cell function in dendritic cell-based vaccines.自然杀伤细胞功能在基于树突状细胞的疫苗中的作用。
Expert Rev Vaccines. 2006 Feb;5(1):55-65. doi: 10.1586/14760584.5.1.55.
8
NK cells at the interface between innate and adaptive immunity.自然杀伤细胞处于固有免疫和适应性免疫的交界位置。
Cell Death Differ. 2008 Feb;15(2):226-33. doi: 10.1038/sj.cdd.4402170. Epub 2007 Jun 1.
9
Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.天然的Vα14(+)自然杀伤T细胞使树突状细胞成熟,从而产生强大的适应性免疫。
Immunol Rev. 2007 Dec;220:183-98. doi: 10.1111/j.1600-065X.2007.00561.x.
10
Early liaisons between cells of the innate immune system in inflamed peripheral tissues.炎症外周组织中固有免疫系统细胞之间的早期联系。
Trends Immunol. 2005 Dec;26(12):668-75. doi: 10.1016/j.it.2005.09.008. Epub 2005 Sep 28.

引用本文的文献

1
Influenza A virus disruption of dendritic cell-natural killer cell crosstalk impacts activation of naïve helper and cytotoxic T cell subsets.甲型流感病毒对树突状细胞与自然杀伤细胞间相互作用的破坏会影响初始辅助性T细胞和细胞毒性T细胞亚群的激活。
Immunohorizons. 2025 Jul 14;9(8). doi: 10.1093/immhor/vlaf024.
2
Tumor-Associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers.肿瘤相关自然杀伤细胞调节癌症中不同的CD8 + T细胞分化程序,并有助于抵抗免疫检查点阻断剂。
Cancer Discov. 2025 Jun 18:OF1-OF23. doi: 10.1158/2159-8290.CD-24-1232.
3
Transcriptional signature of CD56 NK cells predicts favourable prognosis in bladder cancer.
CD56自然杀伤细胞的转录特征预示膀胱癌预后良好。
Front Immunol. 2025 Jan 14;15:1474652. doi: 10.3389/fimmu.2024.1474652. eCollection 2024.
4
Systemic dysregulation and molecular insights into poor influenza vaccine response in the aging population.衰老人群中流感疫苗反应不良的系统性失调和分子机制研究。
Sci Adv. 2024 Sep 27;10(39):eadq7006. doi: 10.1126/sciadv.adq7006.
5
Immunology of Cytokine Storm Syndromes: Natural Killer Cells.细胞因子风暴综合征的免疫学:自然杀伤细胞。
Adv Exp Med Biol. 2024;1448:145-159. doi: 10.1007/978-3-031-59815-9_11.
6
The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity.嵌合抗原受体(CAR)细胞效应器的谱系:抗肿瘤免疫中的作用模式
Cancers (Basel). 2024 Jul 22;16(14):2608. doi: 10.3390/cancers16142608.
7
The Influence of Premature Birth on the Development of Pulmonary Diseases: Focus on the Microbiome.早产对肺部疾病发展的影响:聚焦微生物组。
Metabolites. 2024 Jul 11;14(7):382. doi: 10.3390/metabo14070382.
8
Mitochondrial DNA-boosted dendritic cell-based nanovaccination triggers antitumor immunity in lung and pancreatic cancers.基于线粒体DNA增强的树突状细胞纳米疫苗接种可引发肺癌和胰腺癌的抗肿瘤免疫。
Cell Rep Med. 2024 Jul 16;5(7):101648. doi: 10.1016/j.xcrm.2024.101648. Epub 2024 Jul 9.
9
Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease.细胞游离 NKG2D 配体水平升高可调节 NKG2D 表面表达并损害严重 COVID-19 疾病中的 NK 细胞功能。
Front Immunol. 2024 Feb 12;15:1273942. doi: 10.3389/fimmu.2024.1273942. eCollection 2024.
10
Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment.靶向免疫细胞的小分子:一种癌症治疗的新方法。
Biomedicines. 2023 Sep 24;11(10):2621. doi: 10.3390/biomedicines11102621.